IDEAYA Biosciences (NASDAQ:IDYA) Announces Quarterly Earnings Results

Share on StockTwits

IDEAYA Biosciences (NASDAQ:IDYA) released its quarterly earnings data on Monday. The company reported ($1.30) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.64) by ($0.66), Bloomberg Earnings reports.

NASDAQ:IDYA opened at $6.95 on Tuesday. The business’s 50-day simple moving average is $7.94. IDEAYA Biosciences has a 1 year low of $6.55 and a 1 year high of $16.90.

In other IDEAYA Biosciences news, major shareholder Alexandria Venture Investments acquired 50,000 shares of the stock in a transaction dated Tuesday, May 28th. The stock was acquired at an average cost of $10.00 per share, with a total value of $500,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Several research firms have recently issued reports on IDYA. Jefferies Financial Group began coverage on IDEAYA Biosciences in a research report on Monday, June 17th. They set a “buy” rating and a $14.00 price objective for the company. JPMorgan Chase & Co. began coverage on IDEAYA Biosciences in a research report on Monday, June 17th. They set a “neutral” rating and a $15.00 price objective for the company. Finally, Citigroup began coverage on IDEAYA Biosciences in a research report on Monday, June 17th. They set a “buy” rating and a $20.00 price objective for the company.

IDEAYA Biosciences Company Profile

IDEAYA Biosciences, Inc, an oncology-focused precision medicine company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's product candidate in clinical development is IDE196, a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations.

Further Reading: Diversification in Your Portfolio

Receive News & Ratings for IDEAYA Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEAYA Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Keybank National Association OH Purchases 2,905 Shares of iShares Edge MSCI USA Value Factor ETF
Keybank National Association OH Purchases 2,905 Shares of iShares Edge MSCI USA Value Factor ETF
Keybank National Association OH Lowers Stake in TransUnion
Keybank National Association OH Lowers Stake in TransUnion
Keybank National Association OH Has $469,000 Position in Evertec Inc
Keybank National Association OH Has $469,000 Position in Evertec Inc
Keybank National Association OH Buys 1,119 Shares of International Paper Co
Keybank National Association OH Buys 1,119 Shares of International Paper Co
Keybank National Association OH Invests $474,000 in Teledyne Technologies Incorporated
Keybank National Association OH Invests $474,000 in Teledyne Technologies Incorporated
Keybank National Association OH Trims Stake in Six Flags Entertainment Corp
Keybank National Association OH Trims Stake in Six Flags Entertainment Corp


© 2006-2019 Ticker Report